Tech Company Financing Transactions
Sonire Therapeutics Funding Round
Sonire Therapeutics closed a $18 million Series A funding round on 4/15/2026. Investors included Sante Ventures, Fast Track Initiative and Nomura.
Transaction Overview
Company Name
Announced On
4/15/2026
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series A
Investors
Sante Ventures (Lead Investor) (Dennis McWilliams)
Fast Track Initiative (Koji Yasuda)
Proceeds Purpose
The proceeds will accelerate clinical development, support U.S. regulatory progress following the company's 2024 FDA Breakthrough Device Designation, and advance global commercialization efforts for its innovative non-invasive cancer treatment.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
214 Homer Ave
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Undisclosed
Website
Email Address
Overview
SONIRE Therapeutics Inc. (SONIRE) is developing a next-generation high-intensity focused ultrasound (HIFU) treatment system that uses acoustic engineering (ultrasound) technology created through cutting-edge research conducted by academia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tohru Satoh
Chief Operating Officer
Jun Okamoto
Browse more venture capital transactions:
Prev: 4/15/2026: openmoove venture capital transaction
Next: 4/15/2026: ONTO Health venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs